Selank and semax as potential hepatoprotectors in medical treatment of tuberculosis

Alexey K. Petrovsky, Nikolay A. Smirnov, Vladimir P. Vdovichenko, Tatiana B. Fedorova, Edgar E. Kerbenev, Vladimir N. Fedorov

Open source

DOI
10.3897/rrpharmacology.5.38769
Published
2019-12-16
Container
Research Results in Pharmacology
Publisher
Belgorod National Research University
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3897/rrpharmacology.5.38769,
  title = {Selank and semax as potential hepatoprotectors in  medical treatment of tuberculosis},
  author = {Alexey K. Petrovsky and Nikolay A. Smirnov and Vladimir P. Vdovichenko and Tatiana B. Fedorova and Edgar E. Kerbenev and Vladimir N. Fedorov},
  year = {2019},
  journal = {Research Results in Pharmacology},
  doi = {10.3897/rrpharmacology.5.38769},
  url = {https://doi.org/10.3897/rrpharmacology.5.38769}
}

RIS

TY  - JOUR
TI  - Selank and semax as potential hepatoprotectors in  medical treatment of tuberculosis
AU  - Alexey K. Petrovsky
AU  - Nikolay A. Smirnov
AU  - Vladimir P. Vdovichenko
AU  - Tatiana B. Fedorova
AU  - Edgar E. Kerbenev
AU  - Vladimir N. Fedorov
PY  - 2019
JO  - Research Results in Pharmacology
DO  - 10.3897/rrpharmacology.5.38769
UR  - https://doi.org/10.3897/rrpharmacology.5.38769
ER  - 

APA

Petrovsky, A. K., Smirnov, N. A., Vdovichenko, V. P., Fedorova, T. B., Kerbenev, E. E., & Fedorov, V. N. (2019). Selank and semax as potential hepatoprotectors in medical treatment of tuberculosis. Research Results in Pharmacology. https://doi.org/10.3897/rrpharmacology.5.38769

Source records